Top Markets
Coin of the day
CTI BioPharma Corp. CTI BioPharma Corp.

CTI BioPharma Corp.

CTIC
Classifica tra le azioni #12591
CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery,... CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery, advancement, and commercialization of innovative, targeted treatments for blood cancers within the United States. Its key product is VONJO (pacritinib), an oral kinase inhibitor currently under investigation, specifically designed to target JAK2, FLT3, IRAK1, and CSF1R for the management of adult patients with myelofibrosis. The company holds licensing and collaboration agreements with Teva Pharmaceutical Industries Ltd., SBIO Pte Ltd., and Baxalta. Established in 1991 and based in Seattle, Washington, CTI BioPharma Corp. was previously known as Cell Therapeutics, Inc., adopting its current name in May 2014.
Prezzo delle azioni
$9.09
Ultima sincronizzazione: 2023-06-23
Capitalizzazione di mercato
$567.77M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia CTI BioPharma Corp. (CTIC)

Categoria

Storico del prezzo dell'azione per CTI BioPharma Corp. (CTIC)
Prezzo di chiusura più alto: $9.07 il 2023-06-01

Prezzo di chiusura più basso: $121.75K il 1997-03-01
Storico del prezzo dell'azione di CTI BioPharma Corp. dal 1997 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2023 59.07%
2022 173.23%
2021 -38.21%
2020 161.00%
2019 5.88%
2018 -53.69%
2017 -42.12%
2016 -61.16%
2015 -49.72%
2014 27.27%
2013 38.57%
2012 -76.52%
2011 -49.34%
2010 -67.69%
2009 680.34%
2008 -99.33%
2007 -70.14%
2006 -20.03%
2005 -71.45%
2004 -4.83%
2003 6.48%
2002 -68.99%
2001 -35.93%
2000 997.50%
1999 22.69%
1998 -81.36%
1997 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.01 -13.08%
AU
$138.18 473.58%
US
$759.27 7.20%
CH